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Abstract
Human tumors that lack telomerase maintain telomeres by alternative lengthening mechanisms. Tumors can also form in
telomerase-deficient mice; however, the genetic mechanism responsible for tumor growth without telomerase is unknown.
In yeast, several different recombination pathways maintain telomeres in the absence of telomerase—some result in
telomere maintenance with minimal effects on telomere length. To examine non-telomerase mechanisms for telomere
maintenance in mammalian cells, we used primary cells and lymphomas from telomerase-deficient mice (mTR2/2 and
Emmyc+mTR2/2) and CAST/EiJ mouse embryonic fibroblast cells. These cells were analyzed using pq-ratio analysis,
telomere length distribution outliers, CO-FISH, Q-FISH, and multicolor FISH to detect subtelomeric recombination. Telomere
length was maintained during long-term growth in vivo and in vitro. Long telomeres, characteristic of human ALT cells, were
not observed in either late passage or mTR2/2 tumor cells; instead, we observed only minimal changes in telomere length.
Telomere length variation and subtelomeric recombination were frequent in cells with short telomeres, indicating that
length maintenance is due to telomeric recombination. We also detected telomere length changes in primary mTR2/2 cells
that had short telomeres. Using mouse mTR+/2 and human hTERT+/2 primary cells with short telomeres, we found
frequent length changes indicative of recombination. We conclude that telomere maintenance by non-telomerase
mechanisms, including recombination, occurs in primary cells and is initiated by short telomeres, even in the presence of
telomerase. Most intriguing, our data indicate that some non-telomerase telomere maintenance mechanisms occur without
a significant increase in telomere length.
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Introduction
Telomere length is maintained by the ribonucleoprotein
complex telomerase [1]. However, telomerase expression in
humans occurs primarily in early development, germ cells, and
in stem cells and is not detected in primary cells [2,3]. Most
human tumor cells have detectable telomerase activity, however
some proliferating tumors lack telomerase and thus maintain
telomeres by alternative mechanisms that are collectively termed
ALT for alternative lengthening of telomeres [4,5]. While
mTR2/2 mice have a reduced frequency and rate of tumor
formation, some tumors form and can grow rapidly in these mice
[6,7]. However, the mechanism by which tumors grow in the
absence of telomerase is not known.
Telomerase deficientmicewereinitiallygeneratedbydeletingthe
gene encoding the telomerase RNA (mTR) component [6].
Although mTR2/2 mice lack telomerase activity, no phenotype
is observed in the first generation, due to the long telomeres
observed in laboratory mouse strains [6,8]. When mTR2/2 mice
are bred, progressive telomere shortening occurs in successive
generations. Early generation, mTR2/2G1, mice are obtained by
crossing mTR+/2 mice. Crossing the knockouts through successive
generations results in mTR2/2 G2–G6 generations. Late
generation mTR2/2 G4–G6 mice have short telomeres and show
loss of fertility due to germ cell apoptosis. Wild-derived mouse
strains such as CAST/EiJ have significantly shorter telomere length
distributions, similar to humans [9]. CAST/EiJ mTR+/2 mice
bred for increasing generations show progressive telomere shorten-
ing and loss of tissue renewal capacity [10]. The phenotypes in the
mTR+/2 CAST/EiJ mice mimic the human genetic disease,
dyskeratosis congenita, due to haploinsuffiency for telomerase [10].
Wildtype mice derived from an intercross between late generation
heterozygous parents (termedWT*) have shorter telomeres and also
display tissue renewal defects [10]. Thus, telomere shortening and
consequent loss of tissue renewal capacity occurs in CAST/EiJ mice
even in the presence of telomerase, and provides the opportunity to
examine the effects of short telomeres in the presence of telomerase.
Several lines of evidence indicate that ALT occurs by DNA
recombination in human tumors and immortalized cells [11]. First,
the initial description of ALT demonstrated that the telomeres are
exceptionally long and heterogeneous in human tumors and
immortalized cell lines which lack telomerase [4]. Second, telomere
lengths in ALT cells fluctuate during proliferation, and this
fluctuation can be detected by examining the change in the
telomere lengths at the p- and q-arm of the Y-chromosome in a
rapidly growing culture [11–13]. Third, a unique plasmid sequence
integrated as single copy at the telomere was found duplicated at
other chromosomes following serial transfer of human ALT cells
[14]. ALT associated nuclearpromyelocytic leukemia bodies (APBs)
are found in a subset of human ALT cell lines and contain various
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functional role APBs contribute to ALT mechanisms and they are
often considered as only a marker for some ALT cell lines [16].
Finally, human ALT tumors show frequent telomere sister
chromatid exchanges (T-SCEs), that are detectable using chromo-
some orientation FISH (CO-FISH) [17,18].
Evidence that recombination contributes to telomere length
maintenance was initially discovered in Saccharomyces cerevisiae.Y e a s t
lacking an essential component of telomerase showed progressive
telomere shortening and loss of viability, however survivors appeared
after successive streaking of the colonies [19]. Studies of these yeast
survivors showed that telomere recombination contributes to length
maintenance, and requires the RAD52 pathway [19]. Survivors can
be classified as TypeI or TypeII based ontheir telomere patternsand
growth rate [20,21]. Type I survivors require Rad51, Rad54, Rad55
and Rad57 [22]. The telomeres of Type I survivors are short and the
cells have amplified Y9 sequence. They are likely generated by
Rad51-dependent break-induced replication (BIR). Type II survivors
grow much more rapidly than Type I survivors. They have elongated
telomere sequence tracts, require Rad59, Rad50 and other
components of the MRX complex, and are predominately generated
by Rad51-independent BIR [22,23]. Therefore, in yeast, telomere
elongation in the absence of telomerase occurs mostly though BIR
[22,23]. Studies in Kluyveromyces lactis have also provided insight on
telomere recombination mechanisms. In particular, K.lactis deleted
for telomerase (ter1) showed that telomere recombination is initiated
by short telomeres [24]. In mouse and human cells the T-SCE assay,
which is frequently used to measure telomere recombination, will not
detect recombination by BIR mechanisms. Further, T-SCEs are
exchanges and thus will not result in net telomere elongation as
occurs in BIR. Thus we sought to use other assays to examine
telomere recombination in telomerase null mouse cells.
To examine the role of short telomeres during telomere
recombination in mammalian cells we assayed cells using pq-ratios,
outliers, CO-FISH, and Q-FISH from two different strains of
telomerase deficient (mTR2/2) mice. We found that late passage
CAST/EiJ mouse embryonic fibroblasts (MEFs) and Em-
myc+mTR2/2 lymphomas with short telomeres, exhibit telomere
maintenance with minimal changes to the overall length distribution.
Consistent with telomere recombination, we observed an increase in
pq-ratio changes and outliers in mouse cells with increasing numbers
of short telomeres. We directly showed that subtelomeric recombi-
nation is increased in cells with elevated pq-ratio changes. These pq-
ratio changes were seen associated with short telomeres even in
telomerase positive cells, suggesting that telomerase itself does not
protect against recombination. Our data suggest that, several distinct
recombination-based mechanisms can contribute to telomere
maintenance in mammalian cells.
Materials and Methods
Mice
C57BL/6J mTR2/2 and CAST/EiJ mTR2/2 were gener-
ated as described [6,10]. Mice used for the intergenerational cross
were generated as previously described [25,26]. EmMyc+mTR2/
2 mice were bred and B-cell lymphomas were collected as
previously described [7]. Mice were genotyped by Transnetyx
(Cordova, TN). For serial transfers of tumors, B-cell lymphomas
were isolated from mice and resuspended in PBS at 1610
7 cells/
ml. A total of 1610
6 cells (0.1 ml) were subcutaneously injected
into three SCID mice, two sites each (Taconic). All animals were
housed and bred in a pathogen-free environment and procedures
approved by the Institutional Animal Care and Use Committee at
The Johns Hopkins University.
Primary and Tumor Cell Culture and Metaphase
Preparation
Splenocytes and bone marrow, from the tibias and femurs, were
harvested from 8–10 week old animals. Bone marrow was collected
by flushingthebones with 16PBS, pH 7.4(GIBCO)witha 23-gauge
needle. Cells were resuspended in MarrowMax media (GIBCO), and
immediately incubated with 0.1 mg/ml of KaryoMax Colcemid
solution (GIBCO) for 20 minutes, and harvested for metaphase
spread analysis. Cells wereswelled in 75 mM KCl hypotonic solution
at 37uC for 15 minutes, and fixed with (3:1) methanol: acetic acid
with three repeated exchanges prior to dropping onto slides.
Splenocyte suspensions were generated using 70 mmN y l o nc e l l
strainers (BD Falcon), and were activated in RPMI 1640 with L-
glutamine (GIBCO) supplemented with 16penicillin-streptomycin-
glutamine, 10% heat inactivated fetal bovine serum, 10 mM HEPES
buffer, 1 mM sodium pyruvate (GIBCO), 16 non-essential amino
acids (GIBCO), 50 mM ß-mercaptoethanol (Sigma), 10 mg/ml LPS
(Sigma), 1 U/ml IL-2 (Roche), and 5 mg/ml ConA (Sigma).
Splenocytes were cultured for 48 hours prior to the addition of
0.1 mg/ml of KaryoMax colcemid solution. Cells were incubated in
colcemid for 20 minutes and metaphases prepared as described
above. Lymphomas were collected from mice and single cell
suspensions were generated using a 70 mm nylon cell strainer (BD
Falcon). Cells were grown in a (1:1) mixture of DMEM and Iscove’s
modified Eagle’s media supplemented with 4 mM L-glutamine,
100 Units/ml of penicillin-streptomycin, 100 mMß - m e r c a p t o e t h a -
nol, and 10% heat inactivated fetal bovine serum. Metaphases from
human lymphocytes were acquired as previously described [27].
Mouse embryonic fibroblasts were harvested in 16PBS containing
16 penicillin, streptomycin, and fungizone (PSF, Invitrogen) at
embryonic day 13.5. Cells were incubated in 0.25% trypsin-EDTA
for 20 minutes at 4uC, and further digested at 37uC for 5 minutes.
Cells were transferred to DMEM containing 10% FCS and PSF.
24 hours post plating attached cells were washed in 16PBS and new
DMEM was added and split ,24–48 hours later when cells were
,80% confluent.
Author Summary
Telomeres shorten with each cell division and are normally
maintained by telomerase. Tumor cells typically up-
regulate telomerase to maintain telomeres during rapid
growth; however, some tumors lack telomerase and utilize
alternative mechanisms to maintain the telomeres. Studies
in yeast indicate that recombination contributes to
telomere maintenance in the absence of telomerase. To
examine whether recombination contributes to non-
telomerase mechanisms for telomere maintenance in
mouse and human cells, we utilized mouse primary and
tumor cells, which were genetically deleted for telomerase.
In addition, we assayed human primary cells that had short
telomeres due to reduced telomerase activity. Our data
indicate that cells with short telomeres have an increased
level of telomere recombination, which can occur in
telomeric or subtelomeric regions. We also found that, in
addition to tumor cells, primary cells can utilize non-
telomerase mechanisms for telomere maintenance. Lastly,
we found that, unlike human telomerase negative tumors,
some mechanisms of telomere maintenance do not result
in dramatic telomere lengthening. Thus, mammalian cells
likely utilize several different non-telomerase mechanisms
for telomere maintenance. These findings will be useful for
understanding the process of telomere lengthening in
various types of human tumors.
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(Q-FISH), CO-FISH, and Multicolor FISH
Metaphase spreads were processed for Q-FISH as previously
described [26]. For CO-FISH, the cells were incubated for
24 hours in 30 mMo f5 9-bromo-29deoxyuridine (BrdU, Sigma)
and 10 mM5 9bromo-29deoxycytidine (BrdC, Berry & Associates).
Bone marrow was incubated for 20 minutes and splenocytes for
2 hours in 0.2 mg/ml of colcemid and harvested for metaphases as
described above. Metaphase spreads were rehydrated in 16PBS
pH 7.4 for 15 minutes and fixed in 4% formaldehyde in 16PBS
pH 7.4 for 2 minutes. All washes were done between treatments
with 16 PBS and dehydrated in an ethanol series of 70%, 90%
and absolute ethanol. Slides were treated with 1 mg/ml of pepsin
at 37uC for 10 minutes, fixed in 4% formaldehyde in 16 PBS
pH 7.4, dehydrated and treated with 500 mg/ml of RNase A in
26 SSC for 10 minutes at 37uC, and stained with 0.5 mg/ml of
Hoechst 33258 (Sigma) for 15 minutes at room temperature, air-
dried, and 100 mlo f2 6SSC was added with a cover slip prior to a
30 minute UV exposure at 365 nm in an 1800 Stratalinker
(Stratagene). Slides were digested with 3 U/ml of Exo III in 16
buffer (Promega) for 10 minutes at 37uC. Slides were hybridized
with a telomere probe as described above for Q-FISH. Antibody
staining to BrdU was used in order to avoid metaphases that
underwent two rounds of replication. For BrdU staining, slides
were washed in 26SSC and incubated for 30 minutes at 37uCi n
a 1:100 dilution of FITC anti-BrdU (Molecular Probes, Invitrogen)
in PN buffer (0.1 M NaH2PO4/0.1 M Na2HPO4 pH 8.0, 1%
Triton X-100) as described [28]. The slides were rinsed two times
for 5 minutes each in PN buffer, prior to mounting with
Vectashield. For multicolor FISH the subtelomeric clone
(JHU1193) was acquired from Invitrogen (RPCI-23 391E5) and
purified using HiPure Plasmid Filter Purification kit (Invitrogen). A
mouse chromosome 2 specific paint probe was acquired from
Applied Spectral Imaging (ASI). BAC DNA (1.5 ug) was labeled
by Biotin-Nick Translation (Roche), ethanol precipitated with
15 mg mouse Cot-1 DNA (Invitrogen), and 1.5 mg of fish sperm
DNA (Roche), and resuspended in 10 ml of formamide using a
thermomixer at 37uC. 20 ml of probe hybridization buffer (20%
Dextran sulfate, 26SSC) was added, and the probe was denatured
at 80uC for 5 minutes and pre-annealed at 37uC for one hour.
Slides were pretreated as described for Q-FISH, denatured at
80uC in 70% formamide/26SSC, and dehydrated in an ethanol
series, prior to hybridization for 48 hour at 37uC. Slides are
washed at 45uC in 50% formamide, 26 SSC for 36 5 minutes
and at 60uC in 0.16SSC for 365 minutes. Slides were dipped in
46 SSC/0.1% Tween 20 and 50 ml of denatured and pre-
annealed chromosome 2 paint probe was hybridized for 48 hours
at 37uC. Slides were washed in 0.46 SSC at 72uC for 36
5 minutes and washed 26 2 minutes each in 46 SSC/0.1%
Tween 20. For detection of the BAC hybridization, slides were
blocked in (3% BSA/46SSC/0.1% Tween 20) for 30 minutes at
37uC for 30 minutes. Slides were washed for 2 minutes in 46
SSC/0.1% Tween 20 and streptavidin Alexa Fluor 488 (Molec-
ular Probes, Invitrogen) conjugated antibody was diluted 1:100
and incubated at 37uC for 45 minutes. Slides were washed in 46
SSC/0.1% Tween 20 at 45uC, 365 minutes and dehydrated in
an ethanol series. Slides were stained and visualized as described
for Q-FISH.
Pq-Ratios, Outliers, and Statistical Analysis
Telomere ratios were determined by initially measuring by Q-
FISH the telomere lengths with TFL-Telo (Version 2.0) [29]. For
each chromosome, the telomere signals were scored for location (p
or q), and the final value of q/p was determined for each
chromosome of multiple metaphases. 5-fold ratio values (q/p$5
or q/p#0.2) were plotted and normalized for the total number of
chromosomes examined for each genotype. T-tests were used to
determine statistical significance. Chromosomes with a single
signal-free end were considered to have a q/p greater than 5-fold.
The number of outliers was calculated by generating box plots
using Stata 8.0. The box plots were generated using the Q-FISH
values from the same metaphases examined for telomere ratio
analysis. The test for statistical significance of outliers was done
using the Wilcoxon rank sum test as described [30].
Southern Analysis
Bone marrow and splenocytes were resuspended in 1% PBSa
agarose at a final concentration of 1610
7 cells/ml, incubated in
LDS (1% lithium dodecyl sulfate/100 mM EDTA pH 8.0,
10 mM Tris pH 8.) at 37uC O/N with constant agitation, and
washed twice in 20% NDS for 2 hours at 37uC with constant
agitation. Prior to digestion, plugs were washed twice in TE for
30 minutes and then washed twice in 400 mlo f1 6 Buffer #2
(NEB) for 30 minutes prior to MseI restriction digestion. Plugs
were digested overnight and loaded on a 0.7% TAE agarose gel.
Samples were run at 100V for 6–8 hours. Following denaturation
(0.5 M NaOH/1.5 M NaCl) and neutralization (1.5 M NaCl/
0.5 M Tris-HCL pH 7.4), the DNA was transferred in 206SSC
to a Nylon Membrane (Amersham Hybond N
+) by weighting
method overnight and cross-linked with UV Stratalinker (Strata-
gene). Pre-hybridization was done at 65uC in Church’s buffer for
2 hours. A radioactive telomere probe was made by random-
prime labeling using Prime-It II (Stratagene) with a slight
modification. Briefly, 25 ng of a 500 bp telomeric 59-
TTAGGG/CCCTAA containing probe, acquired from EcoR1
digestion of JHU821 or 1 KB Plus DNA ladder (Invitrogen) was
labeled using 33 mM of dATP, dTTP, 50 mCi of a-
32P dCTP
(3000 Ci/mmol) and 50 mCi a-
32P dGTP (3000 Ci/mmol).
Unincorporated nucleotides were removed using a G50 column
(GE Healthcare). Labeled probe was counted and 10
6 counts/ml
(telomere probe) or 10
5 counts/ml (ladder) was denatured at
100uC for 5 minutes and added to the pre-hybridization solution
and hybridized overnight at 65uC. Membranes were washed 36
15 minutes each in 66 SSC and 1%SDS at 65uC, and 36
15 minutes each in 16SSC and 1% SDS at 65uC and exposed to
a phosphorimager screen and detected on a Fuji phosphorimager.
Results
Telomere Lengths Are Maintained with Minimal Changes
to the Overall Length Distribution
To examine the contribution of non-telomerase mechanisms to
telomere maintenance, we serially passaged CAST/EiJ mTR2/2
mouse embryonic fibroblasts (MEFs), which have short, homoge-
neous telomere lengths [9,31]. After extensive passage, MEF
cultures were immortalized as seen for mTR2/2 MEFs on the
C57BL/6J background (Figure 1A) [6]. Despite extensive passage
of these MEFs, Q-FISH and Southern analysis indicated minimal
changes to the telomere lengths in both mTR+/2 and mTR2/2
cell lines when compared to early passage cultures (Figure 1 D–F,
compare p3 to p29 and p45, data not shown). These findings
indicate that despite immortalization, MEFs lacking telomerase do
not undergo extensive telomere lengthening. We reasoned that
non-telomerase mechanisms for telomere maintenance may be
occurring, similar to Type I survivors in yeast, which result in
telomere maintenance without extensive lengthening.
We next asked whether such maintenance also occurs in
transformed tumor cells lacking telomerase. We utilized Emmyc+
Short Telomeres Initiate Telomere Recombination
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cell specific Em promoter [32]. These mice invariably develop B-cell
lymphoma and die from the tumor by six months of age. We
generated Emmyc+mice with shorttelomeres.The tumor progression
was dramatically reduced in the Emmyc+ mTR2/2 G6 mice with
short telomeres [7]. However some tumors did form in these mice,
and allowed for analysis using Q-FISH (Figure S1A). We first
examined the telomere lengths in primary bone marrow and
splenocytes from Emmyc+mTR+/+,E mmyc+mTR2/2 G1, and
Emmyc+mTR2/2 G 4a n dG 6t u m o r - f r e em i c e( F i g u r eS 1 Ba n dC ) .
In primary cells, the telomere lengths were shorter in the late
Emmyc+mTR2/2 generations compared to the early generations
a n dw h e nc o m p a r e dt oE mmyc+mTR+/+ cells. We next examined
telomere lengths of the tumors that formed in Emmyc+mTR+/+,
Emmyc+mTR2/2 G1, and Emmyc+mTR2/2 G4 and G6 mice.
We found that the telomerase negative tumors did not exhibit
exceptionally longer telomeres when compared to primary bone
marrow or splenocytes (Figure S1A–C). To examine if the telomeres
could be maintained in the absence of telomerase, tumors with short
telomeres (Emmyc+mTR2/2G5) were serially passaged by trans-
plantation into new recipient mice (Figure 1 B and C). Telomere
lengths were examined, and again we observed minimal changes in
telomere length in primary versus secondary lymphomas. Thus we
conclude that both immortalized primary mouse cellsand tumor cells
can maintain telomere lengths in the absence of telomerase using
non-telomerase mechanisms for telomere maintenance.
Pq-Ratio Changes Are Increased in Primary and Tumor
Cells with Short Telomeres
Since we observed that telomerase negative tumors and CAST/
EiJ MEFs appear to be utilizing non-telomerase mechanisms to
maintain telomeres, we sought to determine the basis of this
telomere maintenance mechanism that occurred without signifi-
cant changes to telomere lengths. We examined whether short
telomeres may initiate the non-telomerase maintenance mecha-
nisms operating in these cells. We utilized a previously described
Figure 1. Telomere maintenance occurs in mTR2/2 cells. A. Growth curves for CAST/EiJ MEFs derived from littermates from an HG16HG1
cross. Cells were passaged according to previous reports [31]. Cell growth increased after a brief period of senescence and cells were considered
immortalized after passage 16. B. Q-FISH on myc+mTR+/+ lymphomas serially passaged in SCID mice. C. Q-FISH on myc+mTR2/2G5 lymphomas
serially passaged in SCID mice. D–F. Shown are the Q-FISH analysis of MEFs at passage 3 (p3), passage 29 (p29), and passage 45 (p45). The telomere
lengths of both the HG2 and KO(G2) were not dramatically lengthened. D. The WT2* mean telomere lengths are 3.1610
5, 3.5610
5, and 1.6610
5, the
amount of signal free ends (SFEs) were, 1, 4, and 9, for p3, p29 and p45 respectively. E. For HG2 the mean telomere lengths were 2.6610
5, 2.0610
5,
and 1.8610
5 and the SFEs were, 2, 23, and 19 for p3, p29 and p45 respectively. F. The mean telomere lengths for the KO(G2) were 2.6610
5, 1.5610
5,
and 1.3610
5, and the amount of SFEs were 16, 44, and 156 for P3, p29 and p45 respectively.
doi:10.1371/journal.pgen.1000357.g001
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recombination mechanisms [12]. This assay is based on the Q-
FISH assay, which quantitates the telomere length on metaphase
spreads [29]. As cells divide in culture, both telomeres of a given
chromosome should shorten by similar amounts. This results in a
near constant telomere ratio at the p and q arms for each
individual chromosome in a population of growing cells. However,
if recombination occurs, it will alter the length of at least one
telomere by a random amount. Thus the ratio of the telomere
signal on the two ends of a chromosome that underwent
recombination will differ from the other copies of that chromo-
some in the population. For pq-ratio analysis, we initially
calculated the pq-ratio for mouse chromosome 1 in a population
of growing cells (Figure S2A). Cells expressing telomerase had few
changes in the telomere ratio (Figure S2B). Similar to human ALT
cell lines, we observed that mouse tumor cells lacking telomerase
were increased for changes in the pq-ratios [12] (Figure S2C).
Given that this analysis of a single chromosome could be expanded
to examine the changes within the entire set of chromosomes of a
given metaphase, we proceeded by examining the pq-ratio of
every chromosome in a minimum of ten different metaphases
(Figure 2 and Figure S3). We first examined primary bone marrow
from mTR+/+ mice and early and late generation mTR2/2
mice (mTR2/2G1 and mTR2/2G4). Metaphase spreads were
examined for telomere length using Q-FISH (Figure S1 D and E).
Late generation mTR2/2G4 mice had significantly shorter
telomeres than mTR+/+ or early generation mTR2/2G1 mice.
We next examined the pq-ratios from metaphase spreads from a
population of growing cells and plotted the ratio for each genotype
(Figure 2A–F). To quantitate the changes in the pq-ratios, we
focused on the percent of chromosomes that had a pq-ratio change
of greater than 5-fold (Figure 2G). In mTR+/+ bone marrow the
pq-ratios seldom changed from a value near 1 (Figure 2A, B, and
G). Compared to mTR+/+, mTR2/2G1 primary bone marrow
cells were significantly increased for changes in pq-ratios
(Figure 2C, D and G). mTR2/2 G4 cells with even shorter
telomeres also showed a significant increase in the number of
altered pq-ratios compared to mTR+/+ (Figure 2E, F and G).
These changes in pq-ratios occurred in all metaphases examined,
and were not specific to individual metaphases. Similar findings
were also observed with splenocytes from the same genotypes
(Figure 2G). The greater amount of changes in the pq-ratios in
cells with shorter telomeres likely reflects non-gradual additions or
deletions of telomere sequence that occurs during recombination.
We next asked whether Emmyc+mTR2/2 primary cells with
short telomeres were also increased for changes in the pq-ratios.
Comparisons between Emmyc+mTR2/2G1 and Em-
myc+mTR+/+ primary bone marrow showed a 11-fold increase
in variable pq-ratios (Figure 2H). We also observed a 40-fold
increase in pq-ratio changes between Emmyc+mTR2/2 G4 and
G6 compared to Emmyc+mTR+/+ bone marrow (Figure 2H).
Similar trends were observed in splenocytes (Figure 2H). Thus
similar to mTR2/2 primary cells with short telomeres, Emmyc+
mTR2/2 primary cells with short telomeres were increased for
changes in the pq-ratios.
To determine whether similar changes in pq-ratios occurred in
telomerase negative tumors, we examined Emmyc+ tumors
(Figure 2H and Figure S3). Emmyc+mTR2/2G1 tumors showed
a 37-fold increase in pq-ratios that changed compared to
Emmyc+mTR+/+ tumors. Emmyc+mTR2/2G6 tumors showed
a 52-fold increase compared to Emmyc+mTR+/+ tumors. These
findings suggest that telomerase deficient tumor cells with short
telomeres are likely increased for telomere recombination. We
then compared the number of pq-ratio changes in tumors and
primary cells and found that tumors from both early Em-
myc+mTR2/2 G1 and late Emmyc+mTR2/2 G4/G6 gener-
ation mice were increased in the amount of pq-ratio changes
compared to the primary bone marrow from the same generation
(Figure 2H). Emmyc+ mTR+/+ tumors were also slightly increased
for changes in the pq-ratios compared to Emmyc+mTR+/+
primary cells, perhaps due to selection for increased recombina-
tion during growth of the tumor. Similar observations were made
between the primary splenocytes and tumors. Our data indicate
that telomerase negative tumor cells have an elevated amount of
telomere recombination compared to primary cells. Furthermore,
it illustrates that some non-telomerase telomere maintenance
mechanisms have a minimal effect on the average telomere length.
Outliers Are Increased in Primary and Tumor Cells with
Short Telomeres
While the pq-ratio assay is very sensitive, the data may become
biased as the telomeres shorten. Small changes on a short telomere
may be over-represented and telomeres with no signal will not be
represented at all. Thus we used a second statistical test to assay for
length changes. We determined the distribution of the telomere
lengths and quantitated the number of outliers (Figure 3A), which
are telomere lengths more than two standard deviations from the
median. These outliers numerically represent exceptionally long
and short telomeres in the distribution.
The telomere length distribution acquired from Q-FISH for
each genotype was determined and examined to identify outliers
(shown as dots, Figure 3A). We found mTR2/2G4 bone marrow
and splenocytes cells had a significantly greater number of outliers
per metaphase compared to mTR+/+ cells (Figure 3B). This result
is consistent with the findings observed with the pq-ratio analysis,
and suggests that short telomeres may initiate telomere recombi-
nation.
Emmyc+mTR2/2 Tumors Are Increased for Subtelomeric
Recombination
Our data suggest that abrupt changes in telomere length occur
on short telomeres. To directly test whether recombination is
occurring in these cells, we developed a subtelomeric recombina-
tion assay. We examined the mouse genome sequence for unique
loci contained in subtelomeric regions, and identified a terminal
BAC clone located at H4 on mouse chromosome 2, which also
contained subtelomeric sequences directly adjacent to telomere
repeats in the genome. We initially hybridized this sequence to
mTR+/+ cells to confirm the copy number of this subtelomeric
BAC clone and found the clone hybridized to only two
chromosomal termini in wildtype bone marrow metaphase spreads
(Figure 4A). We reasoned that if recombination in the telomeric
region occurs in the subtelomeric regions, as it does in yeast,
amplification and transfer of this sequence to the telomeres of
other chromosomes would occur. To determine the frequency of
this sequence amplification and transfer, we hybridized metaphase
spreads with both the BAC clone and a chromosome 2 specific
paint probe (Figure 4B and C). We first examined the
Emmyc+mTR2/2 G5 lymphomas. Consistent with subtelomeric
recombination, we observed 51% of the metaphases had amplified
this subtelomeric region in the Emmyc+mTR2/2 G5 lymphomas
with short telomeres (Figure 4D). We observed no metaphases with
amplified subtelomeric sequence in primary mTR+/+ bone
marrow. In the Emmyc+mTR+/+ lymphomas there was a low
level of amplification of this sequence likely due to increased
recombination in the tumors (10%). In addition we observe the
amount of subtelomeric recombination in mTR2/2 MEFs, when
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PLoS Genetics | www.plosgenetics.org 5 January 2009 | Volume 5 | Issue 1 | e1000357Figure 2. Pq-ratio changes are increased in early and late generation in mTR2/2 cells with short telomeres. Telomere fluorescence in
situ hybridization on metaphase spreads from primary bone marrow cells isolated from C57BL/6J mice, (A) mTR+/+, (C) mTR2/2G1 and (E) mTR2/
2G4. Telomeres were hybridized with a Cy3-59 (CCCTAA)3 telomere probe (red) and chromosomes are stained with DAPI (blue). Cy3-fluorescent
intensity correlates with telomere length. B, D, F. The ratios (q/p) of the p and q telomere signals for each chromosome are plotted. 8–15 metaphases
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ratios and the frequency of subtelomeric recombination (unpub-
lished data). Given that early passage primary cells lack fusions, its
unlikely that bridge fusion breakage cycles contribute to the
amplification of the sequence. This subtelomeric amplification and
transfer of a unique locus to additional chromosomes correlated
directly with increased changes in the pq-ratios (Figure 4E),
suggesting that BIR could account for both processes.
Short Telomeres in mTR2/2 Primary Cells from an
Intergenerational Cross Show Increased Recombination
To more specifically examine whether short telomeres are
substrates for recombination, we used mice from an intergener-
ational cross [25,26]. All progeny from this type of cross inherit
chromosomes with 50% short and 50% long telomeres. Previous
studies showed that when late generation mTR2/2 mice were
crossed with mTR+/2 mice, the shortest telomeres were
specifically elongated in mTR+/2 mice [25].
For our analysis, we crossed late generation telomerase mTR2/2
G5 mice with mTR+/2 mice (Figure 5A). Bone marrow was
harvested from mTR2/2 iG6 and mTR+/2 iG6 mice and
analyzed by Q-FISH. We observed that the shortest telomeres from
mTR+/2 iG6 mice were extended, while critically short telomeres
persisted in mTR2/2 iG6 mice (Figure 5B, arrow). When we
examined the pq-ratios, we found a significant increase in the pq-
ratios that changed in mTR2/2 iG6 mice compared to mTR+/2
iG6 mice (Figure 5C). Outlier analysis of telomere lengths from this
intergenerational cross also indicated a significantly greater number
of outliers per metaphase in the mTR2/2 iG6 mice compared to
the mTR+/2 iG6 mice (Figure 5D). These data strongly suggest that
short telomeres are substrates for recombination. We also noted that
themTR+/2iG6mice displayed a smallamount of pq-ratiochanges
and had some outliers. This small, yet detectable amount of pq-ratio
changes and outliers in the mTR+/2 intergenerational mice
suggested that perhaps telomere recombination occurs in the
presence of telomerase.
Short Telomeres Initiate Recombination in CAST/EiJ Mice,
Even in the Presence of Telomerase
To test more directly whether some short telomeres may
recombine in the presence of telomerase, we utilized mTR+/2
CAST/EiJ mice. As described previously, telomere shortening
Figure 3. Late generation mTR2/2 primary cells have a significantly greater number of telomere outliers. Data acquired from Q-FISH
were used to generate box plots. The darkened line within the box represents the 50
th percentile, the median telomere length of the distribution. The
box includes telomere length values and is approximately one standard deviation. The lines extending from outside the box represent approximately
two standard deviations (95
th and 5
th percentile). Telomere lengths outside of these are outliers and appear as dots. Since some data points overlap,
the total amount of outliers is graphically quantitated in B, and is normalized for the total number of metaphases examined. B. The graph shows the
total number of outliers divided by the total number of metaphases (n) for each genotype plotted on the left y-axis. Error bars represent the standard
error of the mean (SEM). Circles reflect the mean telomere length plotted on the right y-axis. Calculated p-values (a=.05) using the Wilcoxon rank
sum test indicate a statistically significant difference between mTR+/+ and mTR2/2G4 bone marrow (P=.004). Similarly mTR2/2G4 splenocytes
have a statistically greater number of outliers in comparison to mTR+/+ splenocytes (P=.008).
doi:10.1371/journal.pgen.1000357.g003
were examined for each genotype. Ratios (q/p) were calculated based on the telomere fluorescent intensity of the p- and q-arms of a given
chromosome. The individual chromosomes assayed for each genotype are shown on the x-axis and the q/p ratio on the y-axis. The y-axis is on a log
scale plot and excludes SFEs, since these values cannot be plotted on log scale. Changes in pq-ratios occurred for all metaphases, and were not
specific to an individual metaphase, which is appreciated given that the chromosomes from each metaphase are graphed from left to right. G. The
bar graph shows the percent of the total number of chromosomes with telomere ratio values of q/p$5-fold (q/p$5 or q/p#0.2). Error bars represent
the standard error of the mean. Values are shown for both primary bone marrow and splenocytes. Student T-tests, assuming a=.05, show statistical
significance and were used to compare WT and mTR2/2G1 bone marrow (P=3.8610
26) and splenocytes (P=8.3610
27). Statistical significance was
also observed between WT and mTR2/2G4 bone marrow (P=3.6610
226) and splenocytes (P=8.8610
218). Circles represent the mean telomere
lengths plotted on the right y-axis. H. Pq-ratio changes determined for primary (pre-tumor) bone marrow and splenocytes as well as B-cell
lymphomas plotted on the left y-axis. Error bars represent SEM. The circles represent the mean telomere length plotted on the right y-axis. Statistical
significance was observed using a T-test (a=.05) between myc+mTR+/+ and myc+mTR2/2G1 primary bone marrow (P=2.3610
28) and splenocytes
(P=6.6610
27). Similarly, statistical significance was observed between myc+mTR+/+ and myc+mTR2/2G4/G6 primary bone marrow (P=1.4610
218)
and splenocytes (P=3.3610
215).
doi:10.1371/journal.pgen.1000357.g002
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and HG#) CAST/EiJ mice [10]. We assayed littermates from
both early and late generation heterozygous intercrosses, including
a cross from the first generation of heterozygous mice (HG1)
which yielded WT2*, HG2, and knockout KO(G2) mice and a
cross of HG5 parents which yielded WT6*, HG6, and KO(G6)
mice (Figure 6A and B). Since telomeres are shorter and more
homogenous in the CAST/EiJ strain compared to C57BL/6J, we
examined telomere length by both Southern blotting and Q-FISH
(Figure 6C and Figure S4 A–C) [9]. We observed that the WT*
mice from the late generation HG5 intercross (WT6*), had shorter
telomeres than true wildtype (WT) and early generation WT2*
mice. We also observed that the telomeres from the late generation
HG6 mice were shorter than HG2 mice. We next examined the
pq-ratio changes and the number of telomere outliers. WT6*,
HG6, and both KO(G2) and KO(G6) mice, had a significant
increase in changed pq-ratios compared to WT mice (Figure 6D
and Figure S4D). These findings illustrate pq-ratios changes
increase in cells with short telomeres, even in the presence of
telomerase. Consistent with this finding, we also observed an
increase in the amount of outliers in bone marrow and splenocytes
cells with short telomeres (Figure 6E and Figure S4E). Together
the pq-ratio and outlier analysis suggest that short telomeres may
initiate recombination even when telomerase is present at wildtype
levels as in the WT6*.
Telomere Sister Chromatid Exchanges Are Detected in
Only a Subset of Primary Cells with Short Telomeres
Since T-SCE has been documented in ALT cells, we wanted to
determine whether this type of recombination could account for
the pq-ratio changes occurring in primary cells. Using the CO-
FISH assay we examined littermates from late generation
(HG56HG5) CAST/EiJ mice and WT CAST/EiJ mice for T-
SCE. Primary bone marrow from WT, WT6*, HG6, and KO(G6)
mice was isolated and examined by CO-FISH (Figure 7). In WT6*
and HG6 mice with short telomeres, we observed only a small
amount of T-SCEs (0.05 T-SCEs/chromosome, Figure 7E).
Similar frequencies were observed in bone marrow from wildtype
mice. In the KO(G6) bone marrow cells the amount of T-SCEs was
significantly higher (0.25 T-SCEs/chromosome) when compared
to WT6* and HG6. However, in splenocytes we observed a similar
frequency of T-SCEs for all genotypes (0.04–0.07 T-SCEs/
Figure 4. Subtelomeric recombination is frequent in Emmyc+mTR2/2G5 tumors. Multicolor FISH using a BAC that maps to the
subtelomeric region (green) of mouse chromosome 2 hybridized to metaphase spreads. Chromosome 2 was hybridized with a chromosome specific
probe (red). Chromosomes with subtelomeric amplification are indicated with a white arrow. A. mTR+/+ bone marrow. B–C. Emmyc+mTR2/2G5
tumors have amplified this subtelomeric sequence to other chromosomes, white arrows. D. Percent of metaphases with subtelomeric amplification
(left, y-axis) and the mean telomere length (right, y-axis). Error bars represent the standard deviation. Subtelomeric amplification is increased in cells
with short telomeres, and also appears at reduced levels in myc+mTR+/+ lymphomas. Fifty metaphases were scored for each genotype. Student T-
tests, assuming a=.05, show statistical significance difference between the myc+mTR+/+ and the myc+mTR2/2G5 lymphomas (P=5.0610
25). E.
Cells with an increased number of pq-ratio changes are also elevated for subtelomeric amplification. Error bars represent the standard deviation.
Student T-tests, assuming a=.05, show statistical significance difference between the myc+mTR+/+ and the myc+mTR2/2G5 lymphomas
(P=6.8610
26).
doi:10.1371/journal.pgen.1000357.g004
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types could be due differences in the type of recombination
mechanism contributing to the telomere maintenance in spleno-
cytes versus bone marrow. The difference in the number of T-
SCEs in the WT6* and KO(G6) bone marrow is unlikely due to
differences in replication rate of these cells, since both genotypes
have similar proliferation rates (Morrish, Armanios and Alder,
unpublished data). Instead the increase in T-SCEs in KO(G6) bone
marrow cells compared to WT6* implies that T-SCEs may be one
type of recombination mechanism that occurs with short
telomeres.
Short Telomeres in Human Cells Show Evidence of
Increased Recombination
While human ALT tumor cells show greatly elongated
telomeres, we wondered if primary human cells with short
telomeres might utilize telomere recombination, without telomere
lengthening. We thus examined both pq-ratios and outliers in
lymphocyte cells from dyskeratosis congenita patients with short
telomeres due to a mutation in hTERT (K902N) (Figure 8A–C)
[27]. Individuals with short telomeres had a significantly greater
amount of changes in pq-ratios in comparison to non-carriers
(hTERT+/+) in the family (Figure 8D). Analysis of the frequency
of outliers per metaphase also demonstrated that carriers with
short telomeres had a significantly greater number of outliers
compared to non-carriers with longer telomeres (Figure 8E). Thus,
short telomeres in human primary cells show evidence of increased
telomere recombination, even in the presence of limiting
telomerase. This data suggests that some telomere maintenance
mechanisms may occur in human cells without a substantial
increase in the telomere length distribution.
Discussion
Short Telomeres Initiate Recombination in Primary
Mammalian Cells
Telomere lengthening is predominantly carried out by telome-
rase, however other mechanisms including recombination can
Figure 5. iG6 mTR2/2 cells from an intergenerational cross have an increase in pq-ratio changes and outliers. A. The breeding scheme
used to generate intergenerational (iG6) mice results in progeny with half short and half long telomeres. B. Q-FISH on primary bone marrow cells
isolated from mTR2/2 iG6 and mTR+/2iG6 mice. The arrow points to the class of shortest telomeres that persist in the iG6 mTR2/2 mice. C.
Summary of pq-ratio analysis on bone marrow cells. Circles represent the mean telomere length. Using a T-test (a=.05) statistical significance was
observed between the number of ratios with q/p$5-fold for mTR2/2 iG6 and mTR+/2 iG6 bone marrow cells (P=2.2610
215). D. Box plot analysis
used to determine the number of telomere ‘‘outliers’’ is plotted on the left y-axis. Circles represent the mean telomere length and are plotted on the
right y-axis. Using a Wilcoxon rank sum test (a=.05), mTR2/2 iG6 bone marrow cells have a statistically greater number of outliers compared to
mTR+/2 iG6 (P=.003).
doi:10.1371/journal.pgen.1000357.g005
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PLoS Genetics | www.plosgenetics.org 9 January 2009 | Volume 5 | Issue 1 | e1000357Figure 6. Short CAST/EiJ telomeres even in the presence of telomerase show increased pq-ratio changes. A and B. Q-FISH on primary
bone marrow isolated from early generation (HG16HG1) and late generation (HG56HG5) CAST/EiJ mice. The breeding scheme used to generate the
CAST/EiJ mice is shown above the Q-FISH plots. C. Southern analysis on bone marrow cells isolated from the same mice shown in A and B. D. The pq-
ratios of primary bone marrow cells are plotted as described above. The percent of the total number of chromosomes with telomere ratio values q/
p$5-fold is plotted on the left y-axis. The circles represent the mean telomere lengths of each genotype plotted on the right y-axis. A T-test (a=.05)
was used to determine statistical significance between WT bone marrow cells versus WT6* (P=.04), HG6 (P=.002), KO(G2) (P=8.8610
25), and KO(G6)
(P=5.9610
211). E. Summary of outliers generated from box plots. The outliers per metaphase are plotted on the left y-axis. The circles represent the
mean telomere length plotted on the right y-axis. A Wilcoxon rank sum test (a=.05) was used to calculate statistical significance between WT versus
HG2 (P=.009), KO(G2) (P=.016) and KO(G6) (P=.0001).
doi:10.1371/journal.pgen.1000357.g006
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PLoS Genetics | www.plosgenetics.org 10 January 2009 | Volume 5 | Issue 1 | e1000357Figure 7. CO-FISH detects frequent exchanges in only some primary mTR2/2 cells. A. A diagram of CO-FISH analysis. In the CO-FISH assay,
cells are grown in the presence of 5-bromo-2-deoxyuridine (BrdU). After one round of replication one strand (green) has incorporated BrdU.
Metaphases are treated with Hoechst and UV treated, which nicks the BrdU incorporated strand. The nicked strands are then degraded with an
exonuclease, followed by hybridization with a telomere probe. B–D. CO-FISH on primary bone marrow cells isolated from the progeny of late
generation (HG56HG5) CAST/EiJ mice WT6* (n=3), HG6 (n=3) and KO(G6) (n=3). WT (n=3) mice were also examined. E. Summary of T-SCEs in
primary CAST/EiJ bone marrow cells. A T-test (a=.05) was used and showed a significant increase in the amount of T-SCEs in primary KO(G6) bone
marrow (P=.003) compared to WT bone marrow.
doi:10.1371/journal.pgen.1000357.g007
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PLoS Genetics | www.plosgenetics.org 11 January 2009 | Volume 5 | Issue 1 | e1000357Figure 8. Lymphocytes from hTERT+/2 individuals are increased for pq-ratio changes and outliers. A and B. Shown are the Q-FISH
results on lymphocytes from various individuals in a family harboring a mutation in hTERT (hTERT+/K902N) or from non-carriers hTERT+/+.C .
Summary of Q-FISH analysis from related individuals with hTERT+/K902N (n=4) and hTERT+/+ (n=6) genotypes. D. The total number of
chromosomes with telomere ratio values q/p$5-fold is plotted on the left y-axis. The black circle denotes the mean telomere length plotted on the
right y-axis. Using a T-test (a=.05), comparison of hTERT+/+ with hTERT+/K902N shows a significant difference (P=.02). E. The total number of
outliers per metaphase is plotted on the left y-axis. Black circles represent the mean telomere length plotted on the right y-axis. Using a Wilcoxon
rank sum test (a=.05) a significantly greater number of outliers were observed in hTERT+/K902N in comparison to hTERT+/+ (P=.034).
doi:10.1371/journal.pgen.1000357.g008
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can stimulate telomere recombination, perhaps due to the loss of
telomere capping [24]. Consistent with recombination occurring
at short telomeres in mammalian cells, we found an increase in pq-
ratio changes and outliers in both telomerase negative and positive
cells. Late generation mTR2/2 cells with the shortest telomeres
showed the greatest amount of pq-ratio changes, and outliers in
primary bone marrow and splenocytes. Furthermore, late
generation mTR2/2 tumor cells were elevated for these changes
compared to primary cells. This increase in telomere length
fluctuation likely occurs by a recombination-based mechanism, as
we found an increased rate of subtelomeric sequence amplification
in cells with short telomeres. Thus like in yeast cells, telomeric and
subtelomeric recombination is elevated at short, possibly dysfunc-
tional telomeres.
The increase in telomeric recombination occurred even in cells
having functional telomerase alleles. Primary cells with short
telomeres from CAST/EiJ WT*, mTR+/2, and in human
samples with mutations in hTERT showed increased telomere
length changes, supporting the idea that telomere recombination
mechanisms can occur in the presence of telomerase. Additionally
the increase in subtelomeric recombination in late passage
mTR+/+ MEFs further demonstrates that both telomerase and
recombination can maintain short telomeres. This increased
telomere recombination at short telomeres in the presence of
telomerase suggest that the telomerase enzyme does not directly
contribute to end protection. Thus, the initiation of telomere
recombination is more likely due to the disruption of the capping
structure at short telomeres, and not the loss of telomerase.
Multiple Mechanisms Alter Telomere Ratios
Studies of survivors in yeast indicate that telomere recombina-
tion can occur by multiple mechanisms. Specifically, two different
survivor pathways have been described for telomere recombina-
tion. Type I survivors have short telomere tracts and BIR occurs in
subtelomeric sequences called Y9 elements. Type II survivors have
long telomere tracts and BIR occurs within the telomere repeats
themselves [20,22]. Our findings suggest that mammalian cells
also can use various types of recombination mechanisms for
telomere maintenance, and that ALT does not occur by a single
mechanism. BIR is considered the predominant mechanism in
yeast for telomere elongation in survivors [23]. We identified an
increased number of metaphases in telomerase deficient lympho-
mas with subtelomeric recombination, indicative of additional
recombination based mechanisms. For instance, degradation of
short telomeres into subtelomeric regions likely exposes various
types of repetitive sequences. When sequence homology with
another chromosome is encountered, strand invasion and copying
of the terminal region occurs. The transfer of this unique
subtelomeric locus from mouse chromosome 2 to different
chromosomes is consistent the possibility of a BIR-like mechanism.
While T-SCEs are typically used as the main measure of
telomere recombination in human ALT cells, it is important to
note that BIR pathways would not be detected by the CO-FISH
method. Although we did detect T-SCE in the bone marrow cells,
the number of T-SCEs did not explain the frequency of telomere
length variations, indicating others mechanisms must also play a
role [33,34]. In addition, CO-FISH is limited when telomeres are
very short, since T-SCEs at short telomeres are very difficult to
detect due to the resolution of the telomere probe [35]. In
addition, some of the accumulating changes in pq-ratios may also
arise as a consequence of stalled replication forks that might be
accompanied with dysfunctional telomeres. In Schizosaccharomyces
pombe, deletion of Taz1, the ortholog of the telomere binding
proteins TRF1 and TRF2, can result in replication fork stalling
[36,37]. These studies suggest that dysfunctional telomeres due to
the immediate loss of telomere end binding proteins in
mammalian cells may result in replication fork stalling, however
such intermediates would be predicted to invoke recombination.
Thus using pq-ratio and outlier analysis allows detection of various
types of recombination.
Non-Telomerase Mechanisms for Telomere Maintenance
in Mouse Cells Have a Minimal Effect on Overall Telomere
Length
The use of ALT for telomere maintenance in human cells has
characteristically been associated with a dramatic lengthening of
telomeres [38]. In contrast, we find in many instances telomere
maintenance can occur without extensive telomere elongation. In
Emmyc+mTR2/2 G6 transgenic mice, short telomeres dramat-
ically limit tumor growth [7]. However, in a few mice, tumors
somehow overcome the short telomeres and continue to grow.
When these Emmyc+mTR2/2 tumors were transferred serially
through several mice the telomere length was not significantly
changed indicating that these tumor cells must utilize non-
telomerase mechanisms for telomere length maintenance. How-
ever, in sharp contrast to many ALT cell lines, telomeres from
these mTR2/2 cells did not exhibit a dramatic telomere
lengthening. This result of telomere maintenance without
significant telomere elongation is very similar to what is seen in
Type I survivors in yeast. In Type I survivors the telomeres are
very short and yet they are maintained following many doublings
and exemplify that not all telomere recombination mechanisms
result in dramatic telomere lengthening [21]. In contrast the
telomere repeat tracts in Type II survivors are dramatically longer
than in wildtype cells. Both Type I and Type II survivors can be
generated in a population of cells. Yet due to the growth
advantage of Type II survivors in liquid culture, only Type II
survivors are seen following extensive growth. The difference
between human ALT tumor cell lines and the mouse tumor cells
shown here suggests that there may be multiple pathways for
recombination in mammals as there are in yeast. One type may
predominate in human ALT tumors and immortalized cells and
another type may be more favored in primary human cells and
mouse cells. Future studies will provide insight into the mechanism
of the different pathways and their requirement for the growth of
tumors in the absence of telomerase.
Supporting Information
Figure S1 Q-FISH analysis on various mTR2/2 cells. A.
Histogram plots of Q-FISH analysis on B-cell lymphomas. B.
Histogram plots of Q-FISH on primary bone marrow from
myc+mTR+/+ and early and late generation myc+ mTR2/2
mice. C. Histogram plots of Q-FISH on primary splenocytes from
the same mice as in B. D. Q-FISH on primary bone marrow show
that the telomeres of late generation mTR2/2G4 cells are
shorter than WT and early generation mTR2/2G1 cells, WT
(n=3), mTR2/2G1 (n=3), mTR2/2G4 (n=2). E. Splenocytes
from the same mice as in D. This FISH data was used to generate
Figures 2 and 3 and Figure S3.
Found at: doi:10.1371/journal.pgen.1000357.s001 (1.70 MB TIF)
Figure S2 Pq-ratios determined for mouse chromosome 1. A.
Shown are the results of a metaphase spread hybridized with
mouse chromosome 1 paint probe (green) and a Cy3-labled
telomere PNA probe (red). B. The pq-ratios for a myc+mTR+/+
lymphoma are plotted on a log-scale and were typically near 1. C.
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lymphoma are variable with some ratios near 10- and 100-fold.
Found at: doi:10.1371/journal.pgen.1000357.s002 (5.04 MB TIF)
Figure S3 Pq-ratios on every chromosome for B-cell lympho-
mas. The pq-ratio plots of every chromosome from multiple
metaphases and similar to analysis for mouse chromosome 1 show
a dramatic increase in pq-ratio changes in myc+mTR2/2G1 and
myc+mTR2/2G6 lymphomas compared to myc+mTR+/+
lymphomas. A and B. Metaphase spreads and pq-ratio plots from
myc+mTR+/+ lymphoma hybridized with telomere probe. C and
D. Metaphase spreads and pq-ratio plots from myc+mTR2/2G1
lymphoma hybridized with telomere probe. E and F. Metaphase
spreads and pq-ratio plots from myc+mTR2/2G6 lymphoma
hybridized with telomere probe.
Found at: doi:10.1371/journal.pgen.1000357.s003 (7.73 MB TIF)
Figure S4 CAST/EiJ mTR2/2 splenocytes are increased in
pq-ratio changes and outliers. Shown is the telomere length
analysis of splenocytes from the mice described in Figure 6. A.
Histogram plots of Q-FISH from the progeny of a HG16HG1
cross: WT2*, HG2 and KO(G2). B. Histogram plots of Q-FISH
from progeny of a HG56HG5 cross WT6*, HG6 and KO(G6).C .
Southern analysis on samples from CAST/EiJ splenocytes of the
genotypes shown in A and B. D. The percent of chromosomes
with a telomere ratio value q/p$5-fold is plotted on the left y-axis.
T-tests (a=.05) on pq-ratio analysis of splenocytes shows a
statistically greater amount of telomeres with ratio values of q/
p$5-fold in HG6 cells in comparison to WT (P=.007). T-tests
(a=.05) comparing WT cells with mTR2/2(G2) (P=4610
29)
and mTR2/2(G6) (P=1.4610
213) show a significantly greater
amount of q/p ratios$5-fold for KO(G2) and KO(G6) Black circles
represent the mean telomere length plotted on the right y-axis.
Error bars represent the SEM. E. The total number of outliers per
metaphase is plotted on the left y-axis. A Wilcoxon rank sum test
was used to test statistical significance (a=.05) between WT and
KO(G6), however no statistical significance was observed (P=0.9).
Black circles represent the mean telomere lengths plotted on the
right y-axis. Error bars represent the SEM.
Found at: doi:10.1371/journal.pgen.1000357.s004 (5.74 MB TIF)
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